Herpes zoster vaccination is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older.

An international research team has successfully identified the initial high-resolution structures of the herpes simplex virus ...

An international research team has determined the first high-resolution structures of the herpes simplex virus origin-binding ...

Pritelivir demonstrated numerically improved efficacy relative to foscarnet, and a more favourable safety and tolerability ...

A second study presented at IDWeek showed that shingles vaccination decreases the risk for death and heart disease — this time among people living with HIV.“Shingles is usually thought of as a painful ...

A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...

The company’s technology, a modified herpes simplex virus used to deliver gene therapies, was given the FDA’s new designation ...

There is more evidence that shingles vaccination significantly decreases the risk for heart disease, dementia and death among ...

A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of ...